Management of Chronic Nonmalignant Pain with Nonsteroidal Antiinflammatory Drugs

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pharmacotherapy

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1592/phco.28.6.788PMID 18503406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.

  2007cited by this paper
• Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

  2007cited by this paper
• Diclofenac and acute myocardial infarction in patients with no major risk factors.

  2007cited by this paper
• Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.

  2007cited by this paper
• Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis

  2006cited by this paper
• Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.

  2006cited by this paper
• Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

  2006cited by this paper
• Adverse cardiovascular effects of rofecoxib.

  2006cited by this paper
• EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

  2006cited by this paper
• Nonsteroidal Antiinflammatory Drugs and Acute Myocardial Infarction in Patients with No Major Risk Factors

  2006cited by this paper
• Time-to-event analyses for long-term treatments--the APPROVe trial.

  2006cited by this paper
• Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats.

  2006cited by this paper
• Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

  2006cited by this paper
• Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials.

  2006cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• Acetaminophen for osteoarthritis.

  2006cited by this paper
• Dose- and time-dependent antiplatelet effects of aspirin

  2006cited by this paper
• An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.

  2006cited by this paper
• Adverse cardiovascular effects of rofecoxib.

  2006cited by this paper
• Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

  2006cited by this paper
• Current Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction

  2005cited by this paper
• Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs

  2005cited by this paper
• Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

  2005cited by this paper
• Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects.

  2005cited by this paper
• Outcome of non-invasive treatment modalities on back pain: an evidence-based review

  2005cited by this paper
• Balancing the gastrointestinal benefits and risks of nonselective NSAIDs

  2005cited by this paper
• Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

  2005cited by this paper
• Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients.

  2005influential reference
• A Nationwide Study of Mortality Associated with Hospital Admission Due to Severe Gastrointestinal Events and Those Associated with Nonsteroidal Antiinflammatory Drug Use

  2005cited by this paper
• Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal inflammatory drugs: Nested case-control study

  2005cited by this paper
• Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

  2005cited by this paper
• Diabetic neuropathies: a statement by the American Diabetes Association.

  2005cited by this paper
• Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs

  2005cited by this paper
• Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction

  2005cited by this paper
• EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

  2005cited by this paper
• Persistent Low Back Pain

  2005cited by this paper
• Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

  2005cited by this paper
• American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force.

  2005cited by this paper
• Clinical practice. Persistent low back pain.

  2005cited by this paper
• Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

  2004cited by this paper
• Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population

  2004cited by this paper
• EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

  2004cited by this paper
• Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial

  2004cited by this paper
• The hepatotoxicity of non‐steroidal anti‐inflammatory drugs

  2004cited by this paper
• Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis.

  2004cited by this paper
• The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.

  2004cited by this paper
• Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications.

  2004cited by this paper
• Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.

  2004cited by this paper
• Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults

  2004cited by this paper
• Selective COX-2 Inhibitors and Risk of Cardiovascular Events

  2004cited by this paper
• The epidemiology of chronic generalized musculoskeletal pain.

  2003cited by this paper
• Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study

  2003cited by this paper
• Oral opioid therapy for chronic peripheral and central neuropathic pain.

  2003cited by this paper
• Pharmacological therapies in fibromyalgia.

  2003cited by this paper
• EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

  2003cited by this paper
• Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tract.

  2003cited by this paper
• Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis

  2003cited by this paper
• Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

  2003cited by this paper
• Unmet needs in the management of neuropathic pain.

  2003cited by this paper
• Maintenance Oral Pantoprazole Therapy Is Effective for Patients With Zollinger-Ellison Syndrome and Idiopathic Hypersecretion

  2003cited by this paper
• Painful sensory neuropathy.

  2003cited by this paper
• Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors.

  2003cited by this paper
• Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

  2003cited by this paper
• Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.

  2003cited by this paper
• Lansoprazole effectively reduces the risk of GI symptom occurrence in ulcer free patients who continue chronic nsaid use

  2003cited by this paper
• Cyclooxygenase isoforms and atherosclerosis

  2003cited by this paper
• Acetaminophen for osteoarthritis.

  2003cited by this paper
• Chronic widespread pain and fibromyalgia: what we know, and what we need to know.

  2003cited by this paper
• Clinical practice. Painful sensory neuropathy.

  2003cited by this paper
• Esomeprazole provides effective control of NSAID-associated upper GI symptoms in patients continuing to take NSAIDs

  2003cited by this paper
• Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark.

  2002cited by this paper
• Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

  2002cited by this paper
• Corticosteroid Injection vs. Nonsteroidal Antiinflammatory Drug and Splinting in Carpal Tunnel Syndrome

  2002cited by this paper
• Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

  2002cited by this paper
• Current perspective on the cardiovascular effects of coxibs.

  2002cited by this paper
• Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine

  2002cited by this paper
• Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.

  2002cited by this paper
• Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction.

  2002cited by this paper
• Guidelines for the management of rheumatoid arthritis: 2002 Update.

  2002cited by this paper
• The Biochemical Selectivity of Novel COX-2 Inhibitors in Whole Blood Assays of COX-isozyme Activity

  2002cited by this paper
• Use of anticonvulsants for treatment of neuropathic pain

  2002cited by this paper
• Cyclooxygenase-2 and atherosclerosis

  2002cited by this paper
• Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors

  2002cited by this paper
• Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?

  2002cited by this paper
• The management of persistent pain in older persons.

  2002cited by this paper
• Guidelines for the management of rheumatoid arthritis: 2002 update.

  2002cited by this paper
• Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study ☆

  2002cited by this paper
• The Management of Persistent Pain in Older Persons

  2002cited by this paper
• Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

  2002cited by this paper
• Effect of H2 Addition on Soot Formation in Fuel-Rich CH4/Air Turbulent Diffusion Flames

  2002cited by this paper
• Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient.

  2001cited by this paper
• Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac

  2001cited by this paper
• Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

  2001cited by this paper
• Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

  2000cited by this paper
• Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines.

  2000cited by this paper
• Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.

  2000cited by this paper
• Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

  1999influential reference
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

  1999cited by this paper

• Chronic pain syndrome management in the elderly: Features, barriers, prospects

  2026cites this paper
• Pain management in hospice and palliative care: A primer for pharmacists.

  2025cites this paper
• Integrating pharmacogenomics into precision pain management

  2022cites this paper
• Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs.

  2022cites this paper
• VA/DoD Clinical Practice Guideline: Diagnosis and Treatment of Low Back Pain

  2019cites this paper
• Carpal Tunnel Syndrome

  2018cites this paper
• Use of strong opioids for chronic pain in osteoarthritis: an insight into the Latin American reality

  2018cites this paper
• THE ANTI-INFLAMMATORY EFFECTS OF FABACEAE AND ALLIACEAE PLANTS : A REVIEW

  2017cites this paper
• Clinical algorithms to aid osteoarthritis guideline dissemination.

  2016cites this paper
• [Not Available].

  2016cites this paper
• Intoxication à la morphine en pédiatrie : un cas clinique

  2016cites this paper
• Celecoxib – the First Selective COX-2 Inhibitor in Clinical Practice

  2015cites this paper
• A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative.

  2014cites this paper
• Deep Tissue Massage and Nonsteroidal Anti-Inflammatory Drugs for Low Back Pain: A Prospective Randomized Trial

  2014cites this paper
• Evaluation of analgesic and anti-inflammatory effects of the crude methanol extract of the stem-bark of Annona senegalensis Pers.

  2014cites this paper
• Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure

  2013cites this paper
• Chronic Pain in the Outpatient Palliative Care Clinic

  2013cites this paper
• [Ibuprofen: safety and efficiency of its use in wide clinical practice].

  2013cites this paper
• Core Competencies Needed to Manage Chronic Pain in the Outpatient Palliative Care Setting

  2013cites this paper
• DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug

  2012cites this paper
• The Management of Chronic Pain in Important Patient Subgroups

  2012cites this paper
• Evaluation of analgesic and anti-inflammatory effects of fresh onion juice in experimental animals

  2012cites this paper
• Pain management in the elderly at the end of life

  2011cites this paper
• A microdialysis study of topically applied diclofenac to healthy humans: Passive versus iontophoretic delivery.

  2011cites this paper
• Analgesics and anti-inflammatory medications in sports: use and abuse.

  2010influential citation
• Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials.

  2010cites this paper
• Symptom management in palliative care and end of life care.

  2010cites this paper
• Understanding and managing patients with chronic pain.

  2010cites this paper
• THE PAIN CONTINUUM: FROM ACUTE TREATMENT TO CHRONIC MANAGEMENT*

  2009cites this paper
• TREATMENT OF PAIN: CURRENT CONCEPTS IN PHARMACOTHERAPY*

  2009cites this paper
• Recent Publications on Medications and Pharmacy

  2009cites this paper
• Recent Publications on Medications and Pharmacy

  2008cites this paper
• Recent Publications on Medications and Pharmacy

  2008cites this paper
• Management of Chronic Pain in Cancer Survivors

  2008cites this paper
• Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy

  2007cites this paper